Autoimmune Disease Therapeutics Market Size to Register USD 153,320 million During the Period 2018 – 2025

0
92

Big Market Research adds Autoimmune Disease Therapeutics Market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years.

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.

Immune system disorders occur due to low activity or over activity of the immune system.

An autoimmune disease is a condition in which the immune system mistakenly attacks and damages its own tissues. There are more than 80 different autoimmune diseases exist. Some of the common types of autoimmune diseases are rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (lupus), inflammatory bowel disease, and others.

Request for a sample copy of this report @ https://www.bigmarketresearch.com/request-sample/2955688/?utm_source=SBL

Autoimmune disease therapeutics are expected to experience significant market growth during the forecast period owing to early diagnosis of the disease, recent launch of advanced therapeutics, and rise in incidence of autoimmune disease. Furthermore, strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other side higher cost associated with the advanced therapeutics is expected to hamper the market growth.

The global autoimmune disease therapeutics market is segmented based on drug class, indication, sales channel, and region. Based on drug class, the market is classified as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. On the basis of indication, rheumatic disease, type 1 diabetes, multiple sclerosis, rare disease, inflammatory bowel disease, and other indications. According to the sales channel, the market is categorized as hospital pharmacy, drug stores & retail pharmacy, and online store. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

Enquiry Before Buying @ https://www.bigmarketresearch.com/purchase-enquiry/2955688/?utm_source=SBL

The major players profiled in this study include: Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, Pfizer Inc and UCB S.A.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.) Biogen Inc., EMD Serono Inc., GlaxoSmithKline plc, Shire Plc., Teva Pharmaceutical Industries Ltd.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Autoimmune Disease Therapeutics Market Key Segments:

By Drug Class: Anti-inflammatory, Antihyperglycemics, NSAIDs, Interferons and Others

By Indication: Rheumatic Disease, Type 1 Diabetes, Multiple Sclerosis, Rare Disease, Inflammatory Bowel Disease and Other Indications

By Sales Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Stores

By Country:

North America: U.S., Canada, Mexico

Europe: UK, Germany, France, Spain, Italy, Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific

LAMEA: Chile, Israel, South Africa, Rest of LAMEA

Table of content:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY FILTER TYPE

CHAPTER 5: AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY APPLICATION

CHAPTER 6: AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal

 5933 NE Win Sivers Drive, #205, Portland,

 OR 97220 United States

 call answer Direct:+1-971-202-1575

 call answer Toll Free:+1-800-910-6452

 email help@bigmarketresearch.com